You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

melanoma

Showing 1 - 25 of 5,258
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Psychoeducation for Uveal Melanoma

Not yet recruiting
  • Uveal Melanoma
  • Education for Intervention
  • Best Practice
  • (no location specified)
Oct 4, 2023

Melanoma Trial in Beijing (IBI363)

Not yet recruiting
  • Melanoma
  • IBI363
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Oct 7, 2023

EVALUATING THE CURRENT STANDARD OF CARE FOR PATIENTS DIAGNOSED

Not yet recruiting
  • Melanoma (Skin)
  • Melanoma
    • (no location specified)
    Jun 2, 2023

    Participation Patterns Among Stage IV Melanoma Patients

    Not yet recruiting
    • Stage IV Melanoma
      • San Francisco, California
        Power Life Sciences
      Oct 16, 2023

      Tumor Skin, Metastatic Melanoma, Melanoma Trial in Orlando, Louisville (OBX-115)

      Active, not recruiting
      • Tumor Skin
      • +2 more
      • OBX-115
      • Orlando, Florida
      • +1 more
      Sep 28, 2023

      Melanoma Trial (Tranexamic acid, Saline)

      Not yet recruiting
      • Melanoma
      • (no location specified)
      Jun 2, 2023

      Uveal Melanoma, Metastatic Cutaneous Melanoma Trial (Autologous Tumor Infiltrating Lymphocytes, Melphalan, Interleukin-2)

      Not yet recruiting
      • Uveal Melanoma
      • Metastatic Cutaneous Melanoma
      • Autologous Tumor Infiltrating Lymphocytes
      • +2 more
      • (no location specified)
      Jun 5, 2023

      Uveal Melanoma Trial in Grand Rapids (Darovasertib)

      Recruiting
      • Uveal Melanoma
      • Grand Rapids, Michigan
        The Cancer and Hematology Centers
      Jun 14, 2023

      Melanoma Trial (Fluzoparib Camrelizumab Temozolomide)

      Not yet recruiting
      • Melanoma
      • Fluzoparib Camrelizumab Temozolomide
      • (no location specified)
      Aug 9, 2023

      Melanoma Trial (ABP 206, Nivolumab)

      Not yet recruiting
      • Melanoma
      • (no location specified)
      Sep 20, 2023

      Monitoring T Cell Responses in Melanoma, Lung and Other Cancer

      Recruiting
      • Clinical Stage III Cutaneous Melanoma AJCC v8
      • +9 more
      • Biospecimen Collection
      • Electronic Health Record Review
      • Rochester, Minnesota
        Mayo Clinic in Rochester
      Oct 4, 2023

      Melanoma, Malignant Melanoma Trial (T3011 + Cobimetinib)

      Not yet recruiting
      • Melanoma
      • Malignant Melanoma
      • T3011 + Cobimetinib
      • (no location specified)
      Mar 3, 2023

      Metastatic Melanoma, Unresectable Melanoma, Acral Melanoma Trial in Tampa (TBio-4101, Cyclophosphamide, Fludarabine)

      Recruiting
      • Metastatic Melanoma
      • +9 more
      • TBio-4101
      • +3 more
      • Tampa, Florida
        Moffitt Cancer Center
      Jan 24, 2023

      Phase of Uveal Melanoma: A Prospective Multi-method Study

      Not yet recruiting
      • Uveal Melanoma
      • Questionnaires and interviews
      • (no location specified)
      Oct 4, 2023

      Profiling of Circulating Immune Cells to Uncover Response

      Not yet recruiting
      • Melanoma
        • (no location specified)
        Nov 23, 2023

        Metastatic Uveal Melanoma Trial in Tampa (ZIV-Aflibercept, Cemiplimab)

        Recruiting
        • Metastatic Uveal Melanoma
        • Tampa, Florida
          Moffitt Cancer Center
        Nov 2, 2023

        Uveal Melanoma Trial in Pittsburgh (Tebentafusp)

        Not yet recruiting
        • Uveal Melanoma
        • Pittsburgh, Pennsylvania
          UPMC Hillman Cancer Center
        Oct 5, 2023

        Stage III Malignant Melanoma of Skin AJCC V6, Stage IV Malignant Melanoma of Skin Trial in Santiago (TAPCells vaccine)

        Completed
        • Stage III Malignant Melanoma of Skin AJCC V6
        • Stage IV Malignant Melanoma of Skin
        • TAPCells vaccine
        • Santiago, RM, Chile
          Faculty of Medicine, University of Chile
        Nov 21, 2023

        PD-1 Refractory Advanced Melanoma Trial in Pittsburgh (Responder-Derived Fecal microbiota transplantation (R-FMT, Pembrolizumab,

        Not yet recruiting
        • PD-1 Refractory Advanced Melanoma
        • Responder-Derived Fecal microbiota transplantation (R-FMT
        • +2 more
        • Pittsburgh, Pennsylvania
          UPMC Hillman Cancer Center
        Sep 1, 2023

        Melanoma Trial in Beijing (tunlametinib, paclitaxel +carboplatin, or temozolomide +cisplatin, or dacarbazine +cisplatin)

        Not yet recruiting
        • Melanoma
        • tunlametinib
        • paclitaxel +carboplatin, or temozolomide +cisplatin, or dacarbazine +cisplatin
        • Beijing, Beijing, China
          Beijing Cancer Hospital
        Aug 15, 2023

        Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma Trial in

        Not yet recruiting
        • Clinical Stage III Cutaneous Melanoma AJCC v8
        • +4 more
        • Nashville, Tennessee
          Vanderbilt University/Ingram Cancer Center
        Feb 28, 2023

        Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7 Trial in Rochester (drug,

        Active, not recruiting
        • Metastatic Melanoma
        • +6 more
        • Rochester, Minnesota
          Mayo Clinic in Rochester
        Jan 13, 2023

        Melanoma Trial (GME751, Keytruda - EU, Keytruda - US)

        Not yet recruiting
        • Melanoma
        • (no location specified)
        Nov 22, 2023

        Uveal Melanoma Trial in Vienna (any therapy suitable)

        Recruiting
        • Uveal Melanoma
        • any therapy suitable
        • Vienna, Austria
          Medical University of Vienna
        Feb 8, 2023

        Analysis of Circulating Exosomes in Melanoma Patients

        Active, not recruiting
        • Melanoma
          • Besançon, France
            CHU de Besançon
          Feb 23, 2023